Close Menu

NIH funding

The SBIR grant could be worth as much as $2.3 million and will help PapGene develop and commercialize its proprietary ovarian and endometrial cancer detection test.

Researchers will study how prior hypoglycemic episodes can result in the "metabolic memory" of persistent vascular complications.

The funds will be used to expand the PharmGKB database and support the activities of the Clinical Pharmacogenetics Implementation Consortium.

Vanderbilt received the grant from NIGMS to establish a new personalized medicine and pharmacogenomics research center.

The funds will support efforts to develop novel data compression strategies for handling various kinds of genomic data.

In addition to a significant increase in NIH's annual funding, the legislation would provide $10 billion over five years for an NIH Innovation Fund.

The recipients of the funding will develop tools to identify certain pathogens often implicated in infections in healthcare settings. 

UC Davis' Simeon Boyd and his colleagues will continue genetic research into the condition to identify biomarkers, which could be used for early detection and treatment.

The database will be used to research new technologies and treatments, as well as to track the health outcomes of children with rare genetic disorders.

The award from the NIH will go toward development of a test for detecting common bacteria from blood with an initial focus on carbepenem-resistant Enterobacteriaceae.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.